Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01200875 · ClinicalTrials.gov registry record
Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 25
- Enrollment target
NCT01200875: Completed study, sponsored by Stanford University.
NCT01200875 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01200875 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Platelet-Rich Plasma (PRP) has been banned in competitive athletes because some people think it may enhance athletic performance. However, there is very little published research to support or undermine this point of view. The purposes of this study are: (1) To assess the effects of local platelet-rich plasma (PRP) therapy on systemic levels of growth factors with suspected or known performance-enhancing effects; and (2) To understand whether the effect of PRP therapy on these growth factors differs between intramuscular and intratendinous PRP injections. This research study is looking for 40 people who are receiving platelet-rich plasma therapy for a tendon or muscle injury. The study involves collecting seven blood samples (2 teaspoons each) from each patient, before and after the PRP treatment. Blood samples may be donated at any location of the patient's choosing, and participants will be paid for their time.
Interventions
- PROCEDURE Ultrasound-guided platelet-rich-plasma (PRP) injection
- PROCEDURE Platelet-Rich Plasma (PRP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-07 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01200875
The ClinicalTrials.gov registry entry for NCT01200875 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ultrasound-guided platelet-rich-plasma (PRP) injection is the first listed.
NCT01200875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01200875 about?
NCT01200875 is a clinical study titled "Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections". Platelet-Rich Plasma (PRP) has been banned in competitive athletes because some people think it may enhance athletic performance. However, there is very little published research to support or undermine this point of view. The purposes of this study are: (1) To assess the effects of local platelet-r...
What is the current status of trial NCT01200875?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2010-07. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01200875?
The interventions under investigation include: Ultrasound-guided platelet-rich-plasma (PRP) injection (PROCEDURE), Platelet-Rich Plasma (PRP) (PROCEDURE).
Who is sponsoring clinical trial NCT01200875?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.